Pharmaceutical Drug

GettyImages/Traitov

OTC makers hit with US FDA warning letters

By Staff Reporter

Two Chinese and one Korean over-the-counter (OTC) drugmakers have received US FDA warnings for violating good manufacturing practice (GMP) regulations for finished pharmaceuticals.

GettyImages/Skarie20

Amneal expands NY site ahead of Impax merger

By Flora Southey

Amneal Pharmaceuticals expects to bring production of some Impax Laboratories’ drugs in-house through a 100,000 sq. ft. expansion at its site in New York state.